Technology Platforms
PolyXen
polyxen

Enhanced performance of peptide and protein drugs using polysialylation.

More about PolyXen

ImuXen
imuxen

Smart vaccines enabled by liposomal delivery.

More about ImuXen

Product Pipeline

Xenetic is developing a biopharmaceutical pipeline with a multi-billion dollar market potential.

View our product candidates

Share Price
Our Partnerships

Xenetic proactively pursues partnerships with biotechnology and pharmaceutical companies

More about the projects with some of our partners

Latest RNS News

14/05/2012

Appointment of VP for Drug Development

03/05/2012

Senior Appointment

View all news

Events Calendar

07.11.11

Xenetic Biosciences to present at Proactive Investors One2One Investor Forum

09.09.11

Xenetic Biosciences CEO invited to Russia-UK VIP Roundtable in Moscow

View all events